He sent a note to Donald Trump pointing out that the president-elect has expressed support for negotiating and calling on him to check out a bill Welch introduced.
Rep. Peter Welch, D-Vt., has introduced legislation to stop pharmaceutical companies from being able to exploit the so-called orphan drug loophole.
U.S. Rep. Peter Welch, D-Vt., has announced that the House Oversight and Government Reform Committee will hold a hearing on prescription drug prices. The hearing will be Wednesday, according to a news release from Welch’s office. The announcement comes less than a week after Welch and a colleague wrote a letter to the committee chair […]
A Leahy spokesperson, when asked whether the senator will give away campaign donations he has accepted from Mylan or its CEO, referred to a statement that didn’t answer the question.
The governor condemned Mylan for raising prices on its EpiPen but defended the company as a good Vermont employer.
A joint committee agreed to a version of S.216 that would require prescription drug manufacturers to justify substantial increases in the “wholesale acquisition cost” of their drugs.
Under the legislation, the attorney general’s office would require drug manufacturers “to provide justification for the increase in the price of the drug.”
Rep. Peter Welch, I-Vt., will be co-chairman of a task force of Democrats in Congress who want to bring down prescription drug prices.